Bann et al. reported that only 1.9% of 4,917 patients on chronic lithium therapy had a PTH determination during follow-up, and even among those with documented hypercalcemia, only 17.2% had a PTH measurement [12]. This evidence concerns the gene PTH and hypercalcemia disease.